Showing results (11-20 of 830) with videos related to

Sort By:
Pageof 83
Angiology|February 1, 1979
Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertensionT Rosenthal, E Kissin, E T Jacob, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Use of oral converting enzyme inhibitor, captopril for lateralizing renal venous renin activityT Rosenthal, B Morag, E Holtzman, et al.
Cancer Metastasis Reviews|February 8, 2002
Malignant cells, directors of the malignant process: role of transforming growth factor-betaB A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Molecular targets and cancer therapeutics: discovery, development and clinical validationBeverly A. Teicher
Current Opinion in Oncology|July 16, 2014
Antibody drug conjugatesBeverly A Teicher
Biochemical Pharmacology|March 6, 2012
Searching for molecular targets in sarcomaBeverly A Teicher
Hematology/Oncology Clinics of North America|April 1, 1995
Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxiaB A Teicher
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Use of perfluorochemical emulsions in cancer therapyB A Teicher
Current Opinion in Pharmacology|June 16, 2010
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugsBeverly A Teicher
Advances in Experimental Medicine and Biology|April 6, 2006
Hypoxia, tumor endothelium, and targets for therapyBeverly A Teicher
Pageof 83